Preparation and Characterization of Nicotine-magnesium Aluminum Silicate Complex-loaded Sodium Alginate Matrix Tablets for Buccal Delivery

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2011 May 20

PMID 21594728

Citations 5

Authors

Sopaphan Kanjanabat

Thaned Pongjanyakul

Affiliations

Soon will be listed here.

Abstract

Nicotine (NCT) buccal tablets consisting of sodium alginate (SA) and nicotine-magnesium aluminum silicate (NCT-MAS) complexes acting as drug carriers were prepared using the direct compression method. The effects of the preparation pH levels of the NCT-MAS complexes and the complex/SA ratios on NCT release, permeation across mucosa, and mucoadhesive properties of the tablets were investigated. The NCT-MAS complex-loaded SA tablets had good physical properties and zero-order release kinetics of NCT, which indicate a swelling/erosion-controlled release mechanism. Measurement of unidirectional NCT release and permeation across porcine esophageal mucosa using a modified USP dissolution apparatus 2 showed that NCT delivery was controlled by the swollen gel matrix of the tablets. This matrix, which controlled drug diffusion, resulted from the molecular interactions of SA and MAS. Tablets containing the NCT-MAS complexes prepared at pH 9 showed remarkably higher NCT permeation rates than those containing the complexes prepared at acidic and neutral pH levels. Larger amounts of SA in the tablets decreased NCT release and permeation rates. Additionally, the presence of SA could enhance the mucoadhesive properties of the tablets. These findings suggest that SA plays the important role not only in controlling release and permeation of NCT but also for enhancing the mucoadhesive properties of the NCT-MAS complex-loaded SA tablets, and these tablets demonstrate a promising buccal delivery system for NCT.

Citing Articles

Screening of the Anti-Neurodegenerative Activity of Caffeic Acid after Introduction into Inorganic Metal Delivery Systems to Increase Its Solubility as the Result of a Mechanosynthetic Approach.

Stasilowicz-Krzemien A, Rosiak N, Miklaszewski A, Cielecka-Piontek J Int J Mol Sci. 2023; 24(11).

PMID: 37298169 PMC: 10252749. DOI: 10.3390/ijms24119218.

Oral Administration of Melatonin or Succinyl Melatonin Niosome Gel Benefits 5-FU-Induced Small Intestinal Mucositis Treatment in Mice.

Uthaiwat P, Priprem A, Chio-Srichan S, Settasatian C, Lee Y, Mahakunakorn P AAPS PharmSciTech. 2021; 22(5):200.

PMID: 34212283 DOI: 10.1208/s12249-021-01941-y.

Characteristic Evaluation of Gel Formulation Containing Niosomes of Melatonin or Its Derivative and Mucoadhesive Properties Using ATR-FTIR Spectroscopy.

Uthaiwat P, Priprem A, Puthongking P, Daduang J, Nukulkit C, Chio-Srichan S Polymers (Basel). 2021; 13(7).

PMID: 33918458 PMC: 8038236. DOI: 10.3390/polym13071142.

Use of propranolol-magnesium aluminium silicate intercalated complexes as drug reservoirs in polymeric matrix tablets.

Pongjanyakul T, Rojtanatanya S Indian J Pharm Sci. 2013; 74(4):292-301.

PMID: 23626384 PMC: 3630724. DOI: 10.4103/0250-474X.107048.

Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets.

Pongjanyakul T, Kanjanabat S AAPS PharmSciTech. 2012; 13(2):674-85.

PMID: 22552930 PMC: 3364405. DOI: 10.1208/s12249-012-9790-7.

References

Diaz del Consuelo I, Falson F, Guy R, Jacques Y . Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. J Control Release. 2007; 122(2):135-40. DOI: 10.1016/j.jconrel.2007.05.017. View

Peppas N . 1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres,.... J Control Release. 2014; 190:31-2. View

Salamat-Miller N, Chittchang M, Johnston T . The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005; 57(11):1666-91. DOI: 10.1016/j.addr.2005.07.003. View

Mihranyan A, Andersson S, Ek R . Sorption of nicotine to cellulose powders. Eur J Pharm Sci. 2004; 22(4):279-86. DOI: 10.1016/j.ejps.2004.03.012. View

Choi H, Jung J, Yong C, Rhee C, Lee M, Han J . Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J Control Release. 2000; 68(3):405-12. DOI: 10.1016/s0168-3659(00)00275-3. View

Batchelor H, Banning D, Dettmar P, Hampson F, Jolliffe I, Craig D . An in vitro mucosal model for prediction of the bioadhesion of alginate solutions to the oesophagus. Int J Pharm. 2002; 238(1-2):123-32. DOI: 10.1016/s0378-5173(02)00062-5. View

Pongjanyakul T, Suksri H . Alginate-magnesium aluminum silicate films for buccal delivery of nicotine. Colloids Surf B Biointerfaces. 2009; 74(1):103-13. DOI: 10.1016/j.colsurfb.2009.06.033. View

Chen L, Chetty D, Chien Y . A mechanistic analysis to characterize oramucosal permeation properties. Int J Pharm. 1999; 184(1):63-72. DOI: 10.1016/s0378-5173(99)00091-5. View

Siepmann J, Siepmann F . Mathematical modeling of drug delivery. Int J Pharm. 2008; 364(2):328-43. DOI: 10.1016/j.ijpharm.2008.09.004. View

10.

Nair M, Chetty D, Ho H, Chien Y . Biomembrane permeation of nicotine: mechanistic studies with porcine mucosae and skin. J Pharm Sci. 1997; 86(2):257-62. DOI: 10.1021/js960095w. View

11.

Sudhakar Y, Kuotsu K, Bandyopadhyay A . Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs. J Control Release. 2006; 114(1):15-40. DOI: 10.1016/j.jconrel.2006.04.012. View

12.

Park C, Munday D . Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm. 2002; 237(1-2):215-26. DOI: 10.1016/s0378-5173(02)00041-8. View

13.

Diaz-Del Consuelo I, Jacques Y, Pizzolato G, Guy R, Falson F . Comparison of the lipid composition of porcine buccal and esophageal permeability barriers. Arch Oral Biol. 2005; 50(12):981-7. DOI: 10.1016/j.archoralbio.2005.04.008. View

14.

Cheng Y, Watts P, Hinchcliffe M, Hotchkiss R, Nankervis R, Faraj N . Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. J Control Release. 2002; 79(1-3):243-54. DOI: 10.1016/s0168-3659(01)00553-3. View

15.

Choi H, Kim C . Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release. 2000; 68(3):397-404. DOI: 10.1016/s0168-3659(00)00276-5. View

16.

Save T, Shah M, Ghamande A, Venkitachalam P . Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine. J Pharm Pharmacol. 1994; 46(3):192-5. DOI: 10.1111/j.2042-7158.1994.tb03776.x. View

17.

Pongjanyakul T, Priprem A, Puttipipatkhachorn S . Investigation of novel alginate-magnesium aluminum silicate microcomposite films for modified-release tablets. J Control Release. 2005; 107(2):343-56. DOI: 10.1016/j.jconrel.2005.07.003. View

18.

Miyazaki S, Nakayama A, Oda M, Takada M, Attwood D . Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol Pharm Bull. 1994; 17(5):745-7. DOI: 10.1248/bpb.17.745. View

19.

Ikinci G, Senel S, Wilson C, Sumnu M . Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. Int J Pharm. 2004; 277(1-2):173-8. DOI: 10.1016/j.ijpharm.2003.10.040. View

20.

Costa P, Sousa Lobo J . Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13(2):123-33. DOI: 10.1016/s0928-0987(01)00095-1. View